Campion Asset Management’s Merck MRK Stock Holding History

Campion Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$618K	Buy	4,806 +45	+0.9%	+$5.27K	0.38%	38
2026 Q1	$573K	Sell	4,761 -39	-0.8%	-$4.5K	0.39%	39
2025 Q4	$505K	Sell	4,800 -12	-0.2%	-$1.13K	0.35%	47
2025 Q3	$404K	Sell	4,812 -695	-13%	-$57.2K	0.29%	57
2025 Q2	$436K	Sell	5,507 -135	-2%	-$10.7K	0.33%	54
2025 Q1	$506K	Hold	5,642	–	–	0.39%	48
2024 Q4	$561K	Sell	5,642 -37	-0.7%	-$3.81K	0.42%	40
2024 Q3	$645K	Sell	5,679 -85	-1%	-$10.1K	0.47%	37
2024 Q2	$714K	Hold	5,764	–	–	0.56%	33
2024 Q1	$761K	Buy	5,764 +62	+1%	+$7.64K	0.59%	30
2023 Q4	$622K	Sell	5,702 -60	-1%	-$6.23K	0.53%	39
2023 Q3	$593K	Hold	5,762	–	–	0.55%	37
2023 Q2	$665K	Buy	5,762 +300	+5%	+$34.1K	0.59%	34
2023 Q1	$581K	Hold	5,462	–	–	0.55%	39
2022 Q4	$606K	Hold	5,462	–	–	0.6%	36
2022 Q3	$470K	Hold	5,462	–	–	0.5%	45
2022 Q2	$498K	Hold	5,462	–	–	0.49%	45
2022 Q1	$448K	Buy	5,462 +330	+6%	+$26K	0.38%	57
2021 Q4	$393K	Hold	5,132	–	–	0.33%	62
2021 Q3	$385K	Hold	5,132	–	–	0.34%	63
2021 Q2	$399K	Sell	5,132 -770	-13%	-$57.3K	0.33%	59
2021 Q1	$434K	Buy	+5,902	New	+$435K	0.33%	59

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Campion Asset Management's MRK Position: Q2 2026 in Review

Campion Asset Management increased its Merck (MRK) stake by 0.95% in Q2 2026, buying an estimated $5.27K and bringing the position to 4,806 shares worth $618K. The position accounts for 0.38% of the portfolio, ranked #38.

Campion Asset Management first reported a position in MRK in Q1 2021 and has held it in 22 quarters since. The position peaked at $761K in Q1 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Campion Asset Management held 4,806 shares of Merck worth $618K as of Q2 2026.
Campion Asset Management bought 45 Merck shares in Q2 2026, an estimated $5.27K.
Merck made up 0.38% of Campion Asset Management's portfolio in Q2 2026, its #38 holding.
Campion Asset Management first reported a position in Merck in Q1 2021 and has held it in 22 quarters since.
Campion Asset Management's Merck position peaked at $761K in Q1 2024.
3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Campion Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.